Cargando…

Mouse models of graft-versus-host disease: advances and limitations

The limiting factor for successful hematopoietic stem cell transplantation (HSCT) is graft-versus-host disease (GvHD), a post-transplant disorder that results from immune-mediated attack of recipient tissue by donor T cells contained in the transplant. Mouse models of GvHD have provided important in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schroeder, Mark A., DiPersio, John F.
Formato:	Texto
Lenguaje:	English
Publicado:	The Company of Biologists Limited 2011
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3097454/ https://www.ncbi.nlm.nih.gov/pubmed/21558065 http://dx.doi.org/10.1242/dmm.006668

Ejemplares similares

Insights into the role of the JAK/STAT signaling pathway in graft-versus-host disease
por: Abboud, Ramzi, et al.
Publicado: (2020)

Selective targeting of histone modification fails to prevent graft versus host disease after hematopoietic cell transplantation
por: Alahmari, Bader, et al.
Publicado: (2018)

Baricitinib-induced blockade of interferon gamma receptor and interleukin-6 receptor for the prevention and treatment of graft-versus-host disease
por: Choi, Jaebok, et al.
Publicado: (2018)

High gastrointestinal microbial diversity and clinical outcome in graft-versus-host disease patients
por: Malard, Florent, et al.
Publicado: (2018)

Pharmacologic Blockade of JAK1/JAK2 Reduces GvHD and Preserves the Graft-Versus-Leukemia Effect
por: Choi, Jaebok, et al.
Publicado: (2014)

Skin-Limited Graft-versus-Host Disease after Pancreatic Transplantation
por: Ilyas, Muneeb, et al.
Publicado: (2017)

Recent advances in graft-versus-host disease
por: Flinn, Aisling M, et al.
Publicado: (2023)

Translational and clinical advances in acute graft-versus-host disease
por: Gooptu, Mahasweta, et al.
Publicado: (2020)

Advances in the treatment of acute graft-versus-host disease
por: Qian, Liren, et al.
Publicado: (2013)

Advance in Targeted Immunotherapy for Graft-Versus-Host Disease
por: Zhang, Lingling, et al.
Publicado: (2018)

Recent advances in ocular graft-versus-host disease
por: Cheng, Xianjing, et al.
Publicado: (2023)

Insights into mechanisms of graft-versus-host disease through humanised mouse models
por: Elhage, Amal, et al.
Publicado: (2022)

Novel pre-clinical mouse models for chronic Graft-versus-Host Disease
por: Verlaat, Lydia, et al.
Publicado: (2023)

NOTCH and Graft-Versus-Host Disease
por: Di Ianni, Mauro, et al.
Publicado: (2018)

Limited Impact of Imatinib in a Murine Model of Sclerodermatous Chronic Graft-versus-Host Disease
por: Belle, Ludovic, et al.
Publicado: (2016)

Graft versus Host Disease in the Bone Marrow, Liver and Thymus Humanized Mouse Model
por: Greenblatt, Matthew B., et al.
Publicado: (2012)

Treatment with Apocynin Limits the Development of Acute Graft-versus-Host Disease in Mice
por: Rezende, Barbara Maximino, et al.
Publicado: (2019)

Targeting IFNGR/IL6R or downstream JAK1/JAK2 to control GvHD
por: Ashami, Kidist, et al.
Publicado: (2018)

Secreted osteopontin from CD4(+) T cells limits acute graft-versus-host disease
por: Aggarwal, Nupur, et al.
Publicado: (2021)

Integrin α3β1 Signaling through MEK/ERK Determines Alternative Polyadenylation of the MMP-9 mRNA Transcript in Immortalized Mouse Keratinocytes
por: Missan, Dara S., et al.
Publicado: (2015)

Single-cell and spatially resolved omics: Advances and limitations
por: Chen, Jiaye, et al.
Publicado: (2023)

Correction: Graft versus Host Disease in the Bone Marrow, Liver and Thymus Humanized Mouse Model
por: Greenblatt, Matthew B., et al.
Publicado: (2013)

Observation of Chronic Graft-Versus-Host Disease Mouse Model Cornea with In Vivo Confocal Microscopy
por: Shimizu, Shota, et al.
Publicado: (2021)

Targeting CXCR4 in AML and ALL
por: Cancilla, Daniel, et al.
Publicado: (2020)

Mobilized peripheral blood: an updated perspective
por: Karpova, Darja, et al.
Publicado: (2019)

Hematopoeitic Cell Transplantation and CAR T-Cell Therapy: Complements or Competitors?
por: Goldsmith, Scott R., et al.
Publicado: (2020)

Regulatory T Cell Therapy of Graft-versus-Host Disease: Advances and Challenges
por: Hefazi, Mehrdad, et al.
Publicado: (2021)

Resolution of Inflammation in Acute Graft-Versus-Host-Disease: Advances and Perspectives
por: Duarte, Layara Roberta Ferreira, et al.
Publicado: (2022)

Reverse Translation in Advancing Pharmacotherapy in Pediatric Rheumatology: A Logical Approach in Rare Diseases with Limited Resources
por: Becker, Mara L., et al.
Publicado: (2017)

Beyond adhesion: emerging roles for integrins in control of the tumor microenvironment
por: Longmate, Whitney, et al.
Publicado: (2017)

Limitations of the biopsychosocial model in psychiatry
por: Benning, Tony B
Publicado: (2015)

T Cell Subsets in Graft Versus Host Disease and Graft Versus Tumor
por: Jiang, Hua, et al.
Publicado: (2021)

Innovations in hematopoietic stem-cell mobilization: a review of the novel CXCR4 inhibitor motixafortide
por: Crees, Zachary D., et al.
Publicado: (2023)

Modifying Graft-versus-Host Disease in a Humanized Mouse Model by Targeting Macrophages or B-Cells
por: Hogenes, Marieke C. H., et al.
Publicado: (2019)

Acute graft versus host disease
por: Jacobsohn, David A, et al.
Publicado: (2007)

Disease Severity and Mortality Can Be Independently Regulated in a Mouse Model of Experimental Graft versus Host Disease
por: Galvani, Rômulo G., et al.
Publicado: (2015)

Graft-versus-host disease may cause pulmonary restriction, but not all restriction is graft-versus-host disease
por: Sheshadri, Ajay, et al.
Publicado: (2022)

Diabetes Limits Stem Cell Mobilization Following G-CSF but Not Plerixafor
por: Fadini, Gian Paolo, et al.
Publicado: (2015)

Murine Models of Steroid Refractory Graft-versus-Host Disease
por: Toubai, Tomomi, et al.
Publicado: (2018)

Advanced brain organoids for neuroinflammation disease modeling
por: Sabate-Soler, Sonia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_u0v1j821dmrun23ao3v13jl2cv